Interim Analysis of the IELSG-19 Randomised Study of Chlorambucil Alone Versus Chlorambucil Plus Rituximab Versus Rituximab Alone in Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma).

Emanuele Zucca(Università della Svizzera italiana), Giovanni Martinelli(University of Bologna), Luca Mazzucchelli(Istituto Cantonale di Patologia), Peter Johnson(Cancer Research UK), Valter Torri(Istituti di Ricovero e Cura a Carattere Scientifico), Monica Bellei(University of Modena and Reggio Emilia), Irene Floriani(Mario Negri Institute for Pharmacological Research), Réda Bouabdallah(Institut Paoli-Calmettes), Catherine Sebban(Ospedale San Giovanni Bellinzona), Daniela Garavaglia, Maurizio Martelli(Sapienza University of Rome), Elı́as Campo(Hospital Clínic de Barcelona), Catherine Thiéblemont(Université Paris Cité), Annarita Conconi(Ospedale degli Infermi), Armando López Guillermo(Ospedale San Giovanni Bellinzona), Stefano Pileri(European Institute of Oncology), Franco Cavalli(Institute of Social and Preventive Medicine), Franck Morschhauser(Hôpital Claude Huriez), Ruth Pettengell(University College Hospital), Andrew Jack(University of Alberta), Alessandra Tucci(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Fabrice Jardin(Laboratoire National Henri Becquerel), Christiane Copie‐Bergman, Liliana Devizzi(Fondazione IRCCS Istituto Nazionale dei Tumori), André Bosly(University of Namur), Emilio Montserrat, Umberto Vitolo(Candiolo Cancer Institute), Graziella Pinotti(Medica (Italy)), Bertrand Coiffier(Unknown)

Blood

November 20, 2009

Cited by 2

|New England Journal of Medicine|2002|3.9k

|New England Journal of Medicine|2018|2.3k

|Blood|2011|2k

|New England Journal of Medicine|2008|1.8k

|New England Journal of Medicine|2013|1.7k

Related Papers